Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
暂无分享,去创建一个
Yusuke Suzuki | B. Julian | J. Novak | Y. Tomino | Hitoshi Suzuki | R. Wyatt | J. Mestecky | Z. Moldoveanu | W. Chatham | W. Chatham | Rhubell Brown | S. Hall | Zhixin Zhang | M. Tomana | Jeannette Y Lee | Run Fan | James W. Robinson | H. Suzuki | Jeannette Y. Lee | S. Hall
[1] M. Kerr,et al. Chapter 9 – Mucosal Immunoglobulins , 2005 .
[2] E. Haddad,et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.
[3] J. Barratt,et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. , 2001, Kidney international.
[4] B. Julian,et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. , 1997, Kidney international.
[5] B. Julian,et al. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. , 2002, Kidney international.
[6] J. Barratt,et al. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. , 2008, Kidney international.
[7] B. Julian,et al. Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy , 2008, Kidney and Blood Pressure Research.
[8] E. Wood,et al. Biology of Disease , 2006 .
[9] Yasuhiko Tomino,et al. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. , 2007, Contributions to nephrology.
[10] B. Julian,et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. , 2005, Kidney international.
[11] F. Alt,et al. The Mechanism and Regulation of Chromosomal V(D)J Recombination , 2002, Cell.
[12] S. Harper,et al. Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy , 1995, Clinical and experimental immunology.
[13] J. Bluestone,et al. The functional significance of epitope spreading and its regulation by co‐stimulatory molecules , 1998, Immunological reviews.
[14] M. Endoh,et al. Immunoglobulin A1 and IgA nephropathy. , 1981, The New England journal of medicine.
[15] N. Saitou,et al. Adaptive evolution of the IgA hinge region in primates. , 2002, Molecular biology and evolution.
[16] M. Cooper,et al. Precursor B cells transformed by Epstein-Barr virus undergo sterile plasma-cell differentiation: J-chain expression without immunoglobulin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Michael,et al. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. , 1980, The Journal of clinical investigation.
[18] J. Berger,et al. Intercapillary deposits of IgA-IgC. , 2000, Journal of the American Society of Nephrology : JASN.
[19] F. Schena,et al. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy. , 1989, Clinical and experimental immunology.
[20] L. Staudt,et al. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Kilian,et al. Chapter 15 – Microbial Evasion of IgA Functions , 2005 .
[22] A. Martini,et al. IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. , 1996, Nephron.
[23] J. Berger,et al. [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.
[24] R. Coppo,et al. Aberrant glycosylation in IgA nephropathy (IgAN). , 2004, Kidney international.
[25] G. Mazzucco,et al. Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity. , 1982, Clinical nephrology.
[26] J. Jennette. The immunohistology of IgA nephropathy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] B. Julian,et al. IgA-containing immune complexes in the urine of IgA nephropathy patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] B. Julian,et al. Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies. , 1987, Clinical immunology and immunopathology.
[29] K. Rajewsky. Clonal selection and learning in the antibody system , 1996, Nature.
[30] A. Woodroffe,et al. IGA NEPHROPATHY—ACCUMULATED EXPERIENCE AND CURRENT CONCEPTS , 1985, Pathology.
[31] Lichuan Yang,et al. Peripheral B lymphocyte β1,3‐galactosyltransferase and chaperone expression in immunoglobulin A nephropathy , 2005, Journal of internal medicine.
[32] J. Woof,et al. Mucosal immunoglobulins , 2005, Immunological reviews.
[33] Michel C Nussenzweig,et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.
[34] G. D'Amico,et al. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] B. Julian,et al. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. , 1993, Contributions to nephrology.
[36] R. Dwek,et al. The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* , 1998, The Journal of Biological Chemistry.
[37] B. Julian,et al. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. , 2007, Contributions to nephrology.
[38] P. J. Van Breda Vriesman,et al. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] J. Xu,et al. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. , 2000, Immunity.
[40] S. Tonegawa,et al. Somatic generation of antibody diversity. , 1976, Nature.
[41] B. Julian,et al. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. , 2007, Molecular immunology.
[42] M. Daha,et al. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation. , 2000, Kidney international.
[43] H. Ploegh,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003 .
[44] G. Alarcón,et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.
[45] B. Julian,et al. IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli , 2004, Journal of Clinical Immunology.
[46] A. Šedivá,et al. Binding sites for carrier-immobilized carbohydrates in the kidney: implication for the pathogenesis of Henoch-Schönlein purpura and/or IgA nephropathy. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[47] J. Berger,et al. Recurrence of IgA nephropathy in renal allografts. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] B. Julian,et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. , 1999, The Journal of clinical investigation.
[49] M. Lamm,et al. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[50] B. Julian,et al. IgA nephropathy: an update , 2004, Current opinion in nephrology and hypertension.
[51] Y. Hiki,et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. , 2001, Kidney international.
[52] B. Julian,et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. , 2007, Kidney international.
[53] J. Barratt,et al. The pathogenic role of IgA1 O‐linked glycosylation in the pathogenesis of IgA nephropathy (Review Article) , 2007, Nephrology.
[54] B. Julian,et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. , 2008, Seminars in nephrology.
[55] S. Harper,et al. Nephrology Dialysis Transplantation Leucocyte B1,3 Galactosyltransferase Activity in Iga Nephropathy , 2022 .